Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ropinirole is a small molecule pharmaceutical drug classified as a dopamine agonist. It is used alone or with other medications to treat the symptoms of Parkinson's disease, such as tremors, stiffness, slowed movements, and balance problems. Ropinirole is also indicated for the treatment of restless legs syndrome (RLS), a neurological disorder characterized by uncomfortable sensations in the legs and an urge to move them. The drug works by mimicking the action of dopamine in the brain, compensating for low levels of this neurotransmitter that are associated with both Parkinson's disease and RLS[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ropinirole.